Gene · 7155
Papers2,315
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 2,315
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Radiation therapy induces immunosenescence mediated by p90RSK. | Front Cardiovasc Med | 2022 | 36426217 | PubTator, text mining | PubMed |
| Role and molecular mechanism of traditional Chinese medicine in preventing cardiotoxicity associated with chemoradiotherapy. | Front Cardiovasc Med | 2022 | 36419486 | PubTator, text mining | PubMed |
| SIRT1 activation and its effect on intercalated disc proteins as a way to reduce doxorubicin cardiotoxicity. | Front Pharmacol | 2022 | 36408244 | PubTator, text mining | PubMed |
| Plasma proteomic characterization of the development of acute kidney injury in early sepsis patients. | Sci Rep | 2022 | 36385130 | PubTator, text mining | PubMed |
| Meta-Analysis of EGF-Stimulated Normal and Cancer Cell Lines to Discover EGF-Associated Oncogenic Signaling Pathways and Prognostic Biomarkers. | Iran J Biotechnol | 2022 | 36381277 | PubTator, text mining | PubMed |
| Genome-Wide Transcriptional Profiling Reveals PHACTR1 as a Novel Molecular Target of Resveratrol in Endothelial Homeostasis. | Nutrients | 2022 | 36364780 | PubTator, text mining | PubMed |
| Intravenous Nicotinamide Riboside Administration Has a Cardioprotective Effect in Chronic Doxorubicin-Induced Cardiomyopathy. | Int J Mol Sci | 2022 | 36361882 | PubTator, text mining | PubMed |
| Multi-Target Potential of Berberine as an Antineoplastic and Antimetastatic Agent: A Special Focus on Lung Cancer Treatment. | Cells | 2022 | 36359829 | PubTator, text mining | PubMed |
| Pharmacogenetics of Drug Metabolism: The Role of Gene Polymorphism in the Regulation of Doxorubicin Safety and Efficacy. | Cancers (Basel) | 2022 | 36358854 | PubTator, text mining | PubMed |
| Artificial Intelligence Predicted Overall Survival and Classified Mature B-Cell Neoplasms Based on Immuno-Oncology and Immune Checkpoint Panels. | Cancers (Basel) | 2022 | 36358737 | PubTator, text mining | PubMed |
| Marine-Derived Compounds Targeting Topoisomerase II in Cancer Cells: A Review. | Mar Drugs | 2022 | 36354997 | PubTator, text mining | PubMed |
| DNA replication initiation shapes the mutational landscape and expression of the human genome. | Sci Adv | 2022 | 36351018 | PubTator, text mining | PubMed |
| DNA-Stimulated Liquid-Liquid phase separation by eukaryotic topoisomerase ii modulates catalytic function. | Elife | 2022 | 36342377 | PubTator, text mining | PubMed |
| All-trans retinoic acid (ATRA) regulates key genes in the RARG-TOP2B pathway and reduces anthracycline-induced cardiotoxicity. | PLoS One | 2022 | 36331922 | PubTator, text mining | PubMed |
| Untangling the roles of TOP2A and TOP2B in transcription and cancer. | Sci Adv | 2022 | 36322662 | PubTator, text mining | PubMed |
| Copy number variant analysis for syndromic congenital heart disease in the Chinese population. | Hum Genomics | 2022 | 36316717 | PubTator, text mining | PubMed |
| Pharmacogenomics in drug-induced cardiotoxicity: Current status and the future. | Front Cardiovasc Med | 2022 | 36312261 | PubTator, text mining | PubMed |
| Alterations in the p53 isoform ratio govern breast cancer cell fate in response to DNA damage. | Cell Death Dis | 2022 | 36307393 | PubTator, text mining | PubMed |
| Topoisomerases I and II facilitate condensin DC translocation to organize and repress X chromosomes in C. elegans. | Mol Cell | 2022 | 36302374 | PubTator, text mining | PubMed |
| DNA Topoisomerase II-α Regulated by miR-22-5p Promotes Hepatocellular Carcinoma Invasion and Migration through the Hippo Pathway. | Oxid Med Cell Longev | 2022 | 36299605 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7155/papers?page=19